Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
4.110
+0.130 (3.27%)
At close: May 12, 2025, 4:00 PM
4.000
-0.110 (-2.68%)
After-hours: May 12, 2025, 7:23 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $44.33 million as of May 12, 2025. Its market cap has decreased by -23.30% in one year.
Market Cap
44.33M
Enterprise Value
20.56M
1-Year Change
-23.30%
Ranking
Category
Stock Price
$4.11
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $44.33M, an increase of 46.15%. That is a compound annual growth rate of 8.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 42.92M | 24.76% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |